Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
MALVERN, PA — TELA Bio (NASDAQ: TELA) has approved inducement equity awards for five newly hired employees, signaling continued investment in talent as the medical technology company advances its commercial-stage …
TELA Bio Grants Equity to New Hires as Medtech Growth Push Continues Read More
MALVERN, PA — On Friday, Ocugen (Nasdaq: OCGN) closed a $22.5 million registered direct stock offering, strengthening its balance sheet as the gene-therapy developer pushes forward with programs targeting blinding …
Ocugen Raises $20.9M to Extend Cash Runway Into Late 2026 Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) said it has repaid at maturity $678 million in principal and accrued interest on its 0.125% convertible senior notes due 2026, a …
Bentley Retires $678M Convertible Debt, Tightening Balance Sheet Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) said preliminary 12-month data from its Phase 2 ArMaDa clinical trial showed meaningful reductions in disease progression for patients with geographic atrophy, a …
Ocugen (NASDAQ: OCGN) Reports Strong Midstage Data for Gene Therapy Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has launched a placebo-controlled Phase 1b proof-of-concept trial of ATI-052, an experimental bispecific antibody aimed at treating atopic dermatitis, marking …
Aclaris Pushes New Antibody Into Skin Disease Trial, Eyes Asthma Next Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) said newly published clinical trial data support the safety and early effectiveness of its experimental gene therapy for Stargardt disease, a rare inherited …
Gene Therapy Slows Vision Loss in Stargardt Trial, Fueling Hope for First Treatment Read More EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) is putting artificial intelligence in the driver’s seat of roadway safety, deploying its Blyncsy analytics platform to help Hawaii spot hazards faster …
AI Eyes Hit the Road: Hawaii Turns Dashcams Into Real-Time Safety Network Read More EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) has quietly pulled off a major technology coup, snapping up Talon Aerolytics and the technology and technical expertise of Pointivo in December …
Bentley’s AI Power Play: Two Acquisitions Turbocharge Infrastructure Analytics Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) is moving toward what could be a defining year, with a late-stage pipeline aimed at some of the most underserved rare skin …
Palvella’s QTORIN Pipeline Targets a Breakout Moment in Rare Skin Care Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) is stepping into one of biotech’s most important global spotlights, with its top executive set to present the company’s gene therapy strategy at …
Ocugen Eyes a Breakout Year as It Takes Center Stage at JPM Healthcare Read More